Top Story

Cancer, infection risk higher among patients treated with IL inhibitors

Cancer, infection risk higher among patients treated with IL inhibitors
October 29, 2019

Read the Perspective from Teri Puhalsky, RN, CRNI


Social media opens new avenue to advocacy in rheumatology

June 21, 2019
Political activism is more accessible than ever thanks to the amplification offered by social media, and rheumatologists can use social media — particularly…
Q&A With Healio Rheumatology

Speaking the Language: Health care execs join United Rheumatology to advocate for independent practice

May 24, 2019
In the ever-changing landscape of the United States health care system, rheumatologists need a voice. They need a voice in managing the complex web of drug pricing…
Meeting News

Congress of Clinical Rheumatology to feature both well-known, 'off the circuit' speakers

April 30, 2019
More than 620 registered attendees from 45 states and 11 countries are traveling to Destin, Florida, this week for the 2019 Congress of Clinical Rheumatology, scheduled…
More Headlines »

3rd Annual Association of Women in Rheumatology National Conference: Immunology Bootcamp - Best Of!

This activity is supported by educational grants from AbbVie, Inc.; Amgen Inc.; Bristol-Myers Squibb; Genentech, Inc.; GlaxoSmithKline; Lilly USA, LLC; Merck & Co., Inc.; and Sanofi Genzyme and Regeneron Pharmaceuticals.

Immune-mediated inflammatory diseases (IMIDs) are a group of clinically heterogeneous disorders, including rheumatoid…
More »
Meeting News

HOP-STEP program builds plan for 'pregnancy success' in patients with lupus

August 20, 2019
More »

Systemic Sclerosis Interstitial Lung Disease: Early Diagnosis and Comprehensive Management

This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals.

Interstitial lung disease (ILD) is a frequent complication of the autoimmune disorder systemic sclerosis (SSc). SSc-ILD…
More »